Watchlist Price Alert

Esperion Therapeutics Inc... (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

1.04

0.00 (0.00%)

At close: Jun 24, 2025, 12:45 PM

Esperion Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	144.76M	82.25M	124.78M	208.89M	304.96M	166.13M	36.97M	34.47M	38.16M
Short-Term Investments	n/a	n/a	42.09M	50.44M	n/a	34.65M	99.05M	165.73M	173.42M
Long-Term Investments	n/a	n/a	42.09M	50.44M	n/a	34.65M	99.29M	239.15M	204.32M
Other Long-Term Assets	n/a	n/a	-42.09M	50M	-7.36M	-34.65M	-99.05M	-165.73M	-173.42M
Receivables	80.14M	48.49M	33.73M	22.93M	12.39M	n/a	n/a	n/a	n/a
Inventory	94.49M	65.62M	35.2M	34.39M	16.14M	n/a	n/a	n/a	n/a
Other Current Assets	18.02M	4.51M	9.87M	n/a	n/a	928K	n/a	n/a	n/a
Total Current Assets	338M	201.06M	246.68M	328.97M	345.9M	211.71M	142.63M	203.92M	213.58M
Property-Plant & Equipment	5.77M	4.67M	1.2M	2.56M	7.31M	2.68M	520K	435K	674K
Goodwill & Intangibles	56K	56K	56K	56K	56K	56K	56K	56K	56K
Total Long-Term Assets	5.82M	4.73M	1.26M	52.62M	7.36M	2.73M	819K	73.91M	31.64M
Total Assets	343.82M	205.8M	247.94M	381.59M	353.26M	214.45M	143.45M	277.83M	245.21M
Account Payables	51.65M	31.72M	23.04M	17.56M	51.98M	28.86M	44.89M	20.38M	4.59M
Deferred Revenue	8.52M	25.4M	3.51M	5.68M	1.66M	2.15M	n/a	38K	40K
Short-Term Debt	54.58M	34.83M	24.76M	11.29M	5.39M	5.24M	n/a	1.04M	1.71M
Other Current Liabilities	60.33M	49.24M	29.02M	24.7M	19.5M	22.96M	1.88M	10.99M	n/a
Total Current Liabilities	246.23M	156.22M	92.31M	73.35M	94.07M	66.08M	64.33M	33.14M	15.59M
Long-Term Debt	240.29M	501.55M	259.9M	258.28M	179.37M	n/a	n/a	n/a	1.02M
Other Long-Term Liabilities	246.02M	n/a	218.84M	245.74M	172.5M	127.31M	n/a	n/a	n/a
Total Long-Term Liabilities	486.31M	504.57M	479.41M	505.18M	355.32M	128.42M	n/a	n/a	1.02M
Total Liabilities	732.54M	660.79M	571.72M	578.53M	449.39M	194.5M	64.33M	33.14M	16.61M
Total Debt	297.6M	540.95M	260.95M	260.2M	185.41M	1.56M	n/a	1.04M	2.73M
Common Stock	196K	118K	75K	61K	26K	27K	27K	26K	23K
Retained Earnings	-1.6B	-1.55B	-1.34B	-1.11B	-838.82M	-695.27M	-598.1M	-396.29M	-229.2M
Comprehensive Income	n/a	n/a	-2K	-31K	0.00	23K	-319K	-845K	-172K
Shareholders Equity	-388.72M	-454.99M	-1.34B	-1.11B	-838.82M	-695.27M	-598.1M	244.69M	228.6M
Total Investments	n/a	n/a	84.17M	100.88M	n/a	69.3M	99.29M	239.15M	204.32M